Form 8-K - Current report:
SEC Accession No. 0001615774-18-001692
Filing Date
2018-03-08
Accepted
2018-03-08 16:06:06
Documents
3
Period of Report
2018-03-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s109277_8k.htm 8-K 15414
2 EXHIBIT 99.1 s109277_ex99-1.htm EX-99.1 53042
3 GRAPHIC img001_v1.jpg GRAPHIC 34923
  Complete submission text file 0001615774-18-001692.txt   117698
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA GENETICS INC (Filer) CIK: 0001488039 (see all company filings)

EIN.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35610 | Film No.: 18676489
SIC: 2834 Pharmaceutical Preparations